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Introduction 32
It is indisputable that the Western honeybee Apis mellifera suffers from the negative effects of 33 inappropriate use of pesticides 1 and a range of parasites and diseases 2 . The most important 34 parasite today is the ectoparasitic mite Varroa destructor. The emergence of V. destructor is 35 the result of a host shift that occurred when A. mellifera and the Asian Hive Bee, A. cerana, 36 were brought into contact by beekeepers in the 1930s 3 . 37
Varroa destructor (hereafter simply referred to as Varroa) is aptly named. When left 38 untreated, Varroa typically destroys the colonies of its host 4 . In Europe and the United States 39 managed honeybee colonies suffer greatly from Varroa and require constant treatment with 40 miticides to prevent colonies from dying. At the same time, wild or feral honeybee populations 41 have been decimated or gone extinct 5 . 42
Varroa females feed on the haemolymph of the developing bees and in doing so are thought 43 to vector viruses carried therein 6, 7 . Although a variety of viruses could potentially be 44 transmitted by Varroa 8 , one in particular -Deformed wing virus (DWV) -is strongly 45 associated with Varroa. For example, as Varroa sequentially invaded the islands of Hawaii, 46 viral titres of DWV increased, while the diversity of DWV viral strains decreased, such that a 47 single strain came to dominate after a few years 9 . A similar phenomenon was seen in New 48
Zealand where titres of DWV dramatically increased with the length of exposure to Varroa 10 . 49
Vector-based transmission is predicted to lead to an increase in virulence because it changes 50 the evolutionary trade-off between virulence and transmission 11 . While an obligate parasite is 51 selected to replicate quickly, so that it can infect as many hosts as possible, a high rate of 52 replication may kill the host before the parasite is transmitted to its next host. Selection will 53 thus act against a pathogen that kills or immobilises its host if this reduces its long-term 54
At first glance the association between Varroa and DWV seems to fit the predicted change in 66 virulence after the arrival of a vector, and thus a change in mode of transmission. However, 67 honey bees host many viruses that are both common and widespread 8, 15 including viruses that, 68 like DWV, are present in Varroa and can also be vector-transmitted (eg. viruses of the Acute 69 bee paralysis virus complex (ABPV and Kashmir bee virus, etc.) 16 ). This raises the question: 70 why has DWV become synonymous with Varroa infestation, but not other honey bee viruses? 71 An alternative explanation for the observed association is that more virulent viruses are 72 eliminated from the population due to excessive host mortality following vector-based 73 transmission, thereby allowing less virulent DWV to take the upper hand 10, 17, 18 . Here we test 74 this alternative explanation empirically using a population of honeybees naïve to both Varroa 75 and DWV. 76 We experimentally changed the transmission of bee viruses from horizontal (via faeces and 77 feeding) to vector-mediated transmission by performing a serial passage experiment. We 78 injected extracts from bee pupa to bee pupa repeatedly for up to 30 transmission cycles and 79 found that two viruses naturally present in our bee population, Sacbrood virus (SBV) and Black 80 queen cell virus (BQCV), rapidly increased in titre. In contrast, DWV introduced via injection 81 rapidly decreased in titre accompanied by a rapid increase in titres of SBV and BQCV. More 82 importantly, DWV alone did not cause mortality in pupae, whereas injection with serially 83 passaged bee extracts containing high titres of SBV and BQCV did. We conclude that the 84 observed association between Varroa and DWV may not necessarily be due to Varroa 85 increasing the virulence of DWV, but could be explained by Varroa eliminating other viruses 86 that become more virulent when the mode of transmission changes. 87
Results 89

Experimental overview 90
To mimic the effects of changing to a new, vector-based transmission route we serially injected 91 honey bee pupae with viruses and monitored the changes in virus levels. Injecting honeybee 92 extracts into pupae has previously been used to incubate viruses prior to serological 93 experiments 19 and to obtain standardised inoculum for injection experiments 20 . We adapted this 94 protocol to conduct serial transmission of honeybee extracts by pupal injection for 20+ 95 transmission cycles. We performed two independent transmission experiments with different 96 starting inoculum: (1) extracts obtained from asymptomatic (DWV-naïve) honeybees; and (2) 97 extracts obtained from symptomatic (DWV-infected) honeybees. 98 99
Serial transmission of asymptomatic (DWV-naïve) inoculum 100
In our first experiment ( Figure 1A ; Serial Transmission 1), we took our starting inoculum from 101 adults sampled from three asymptomatic honeybee colonies from Sydney, Australia (lacking 102 DWV and naïve to Varroa, referred to hereafter as colonies 1, 2 and 3). We subjected white-103 eyed pupae from the same three colonies to each of three treatments: (1) pupae injected with 104 inoculum containing viruses; (2) pupae injected with extraction buffer as a procedural control 105 ('buffer'); and (3) pupae left unmanipulated ('control'). After 4 days, we harvested pupae for 106 extraction to generate inoculum for the next transmission cycle. We passaged inoculum for 20 107 transmission cycles (18 for colony 3; see Materials and Methods) . 108
We used end-point PCR to screen for the presence of the five known viruses present in 109 Australia 21 in our initial adult workers and in pupae sampled at regular intervals during the 18-110 20 serial transmission cycles. We detected two just two viruses: Sacbrood virus (SBV) and 111 Black Queen Cell virus (BQCV). Control pupae did not test positive for SBV and BQCV. In 112 contrast, buffer-injected procedural controls occasionally tested positive for SBV and BQCV. 113 It has been well documented that the effect of injection procedure alone can cause the irruption 114 of latent viral diseases in bees 19 , in line with our observations of SBV and BQCV in our buffer, 115 but not unmanipulated, control pupae. 116
117
Serial transmission results in a rapid increase in viral titre 118
To determine whether serial transmission resulted in increased viral titres, we assessed 119 expression levels of SBV and BQCV using quantitative PCR and compared those to the 120 expression levels of two endogenous control genes, Actin and Rps5 (see Materials and 121 or 20 (colonies 1 and 2) into pupae sourced from an independent colony and performed qPCR 124 on these samples, together with buffer-injected and unmanipulated controls. 125
Both SBV and BQCV virus showed a rapid increase in titre ( Figure 2 , Table S2 ). Compared 126 to control and buffer-injected pupae, BQCV levels increased in pupae injected with bee extract 127 after only one transmission cycle, after which levels remained the same (Figure 2 A) . Levels of 128 SBV remained low after one transmission cycle but had increased by transmission cycle 5 and 129 remained high thereafter (Figure 2 B) . 130
To correlate viral titres as measured by qPCR to total RNA content, we examined the amount 131 of viral RNA in pupae injected with bee extract after 20 transmission cycles (colonies 1 and 2, 132 as colony 3 was no longer available due to the loss of the colony's queen) using HiSeq 133 (Illumina) total RNA sequencing. BQCV and SBV levels made up the vast majority of non-134 ribosomal RNA in pupae, collectively accounting for 92.6% and 86% of total RNA in colony 135 1 and 2 pupae, respectively. BQCV levels reached approximately 60%, while SBV levels 136 ranged between 26-35% (Figure 3 A, Table S3 ). 137 138
Serial transmission of DWV results in a decrease in DWV titre 139
We then repeated our serial transmission experiment ( Figure 1A , Serial Transmission 2) using 140 inoculum obtained from 5 symptomatic, DWV-infected adult bees from New Zealand (see 141 Material and Methods, including details of quarantine permits), and injecting into lab reared 142 pupae obtained from 2 independent recipient honeybee colonies (referred to as colony 4 and 5; 143 naïve to both DWV and Varroa). We passaged inoculum for 30 transmission cycles. We 144 quantified the total amount of viral RNA in the initial adults (DWV source) and after 1, 10, 20 145 and 30 transmission cycles in pupae 4 days post-injection, along with buffer-injected and 146 control pupae taken from cycle 20 using HiSeq (Illumina) sequencing (Figure 3 B , Table S3 ). 147
Almost 90% of non-ribosomal RNA came from DWV in our original inoculum, suggesting 148 that the viral load of symptomatic honey bees can reach extreme levels (Figure 3 B ; 'DWV 149 source'; Table S3 ). After one transmission cycle, DWV levels reached 25-32% of total non-150 ribosomal RNA in injected pupae from both colonies. Thereafter, DWV levels decreased 151 rapidly until only a small amount (<10%) of RNA could be attributed to DWV after 10 152 transmission cycles (Figure 3 B ; Table S3 ). The decrease in DWV titres was accompanied by 153 an increase in BQCV and SBV titre (Figure 3 B) , similar to the increase seen in our serial 154 transmission experiment without the inclusion of DWV (Figure 3 A) . In the buffer injected 155 pupae from colony 4, we also saw high levels of SBV, indicating that the injection procedure 156 alone can result in increase in endogenous virus levels, in line with previous observations 19 .
We also saw a shift in DWV strain composition. DWV is known to comprise of 3 main master 158 variants: strain DWV-A, DWV-B and DWV-C 22,23 . Strain A is globally associated with 159 increased viral titres and colony decline 9,24 . Strain B is an emerging DWV genotype that has 160 increased virulence compared to DWV-A in laboratory experiments, but has also been found 161 in colonies that seem to cope with the presence of Varroa 17,20,22,23 (the effect of strain C is 162 currently unknown). Our original inoculum contained low amounts of strain B (0.34% of total 163 viral RNA) which had increased after 20 transmission cycles, particularly in colony 5 (1.66%), 164 only to drop again after 30 cycles (Figure 3 B , Table S3 ). The total amount of RNA attributable 165 to virus ranged between 88-97% in pupae injected with virus inoculum at all cycles tested, in 166 contrast with control (0.3-0.4% virus) and buffer samples (62% in colony 4 (mentioned above), 167 and 0.18% in colony 5). Overall survival was significantly affected by treatment in both assays (respectively c 2 4 = 179 235.68, p < 0.00001, n = 300 and c 2 4 = 355.21, p < 0.00001, n = 300; Table S4 ). Mortality of 180 pupae when injected with DWV alone was not statistically different from buffer-injected 181 controls (both p > 0.153; Figure 4 , Table S4 ). When pupae were injected with cycle 20 inoculum 182 from both serial transmission experiments, mortality between inoculum with and without DWV 183 were not statistically different (both p > 0.068; Figure 4 , Table S4 ). In both instances, mortality 184 was much higher compared to buffer-injected pupae and pupae injected with DWV alone (all 185 p < 0.00001; Figure 4 , Table S4 ). Clearly, increased mortality is due to the increased titres of 186 SBV and BQCV, not due to the presence of DWV. When testing the effect of 'source colony' 187 on pupae survival we found that our first source colony had a significantly higher survival than 188 the second (c 2 1 = 4.90, p = 0.0268, n = 600). However, the overall result was the same for both 189 colonies. 'Replicate' had no significant effect on survival in both colonies (respectively c 2 4 = 190 5.87, p = 0.209, n = 300 and c 2 4 = 8.84, p = 0.065, n = 300, Table S4 ).
Discussion 193
We aimed to investigate the effect of changing the route of transmission, from horizontal and, 194 in some cases vertical, to vector-transmitted, to determine if such a change in route of 195 transmission alone is sufficient to increase virulence of RNA viruses contained in the 196 haemolymph of honeybees. We found that two viruses, Sacbrood virus (SBV) and Black queen 197 cell virus (BQCV) rapidly increased in titres when injected into white-eyed pupae. In contrast, 198 when we injected inoculum containing high titres of Deformed wing virus (DWV) strain A, 199 DWV viral titres rapidly decreased, most likely due to competition with SBV and BQCV. 200 Interestingly, injecting high titres of DWV strain A into pupae did not result in the death of the 201 pupae, indicating that this strain of DWV does not kill developing brood. Injecting high titres 202 of SBV and BQCV did result in high mortality. 203
Both SBV and BQCV are brood diseases; young larvae normally become infected early on 204 via feeding by adult bees 25 . When brood dies from either virus, nurse bees will remove and 205 partially cannibalise the dead brood, thus themselves accumulating the virus. Because both 206 viruses end up in the bees' hypopharyngeal gland (in which brood food is produced), nurse bees 207 transmit the viruses when feeding young larvae 25 . Under natural conditions, and in the absence 208 of Varroa, both SBV and BQCV were found to occur at a frequency of around 10% in summer 209 in Britain using immunodiffusion tests 26 . Both viruses are easily detected when bee extract from 210 adult bees is injected into pupae 27 , indicating that both viruses are present at low incidences 211 without causing overt infections, and readily amplify upon injection into pupae. In Australia, 212 BQCV was found in 65% and SBV in 35% of hives using more sensitive molecular detection 213 methods, further indicating high viral prevalence in the absence of overt infections 21 . Our 214 results suggest that repeated vector-mediated transmission of bee extract containing SBV or 215 BQCV will rapidly lead to such high viral titres that the brood never develops to adulthood. 216
Our experimental conditions were restricted to pupae, as our quarantine permits required 217 injected pupae to be terminated prior to eclosion. Therefore, our results reflect conditions that 218 are favourable to replication in brood, as we harvested injected pupae randomly, regardless of 219 Clearly honeybee colonies contain a number of different viruses, both of different species as 239 well as different strains of the same species given the high mutation and replication rates of 240 RNA viruses 29 . Competition amongst viruses drives virulence 30,31 . Inevitably some viruses are 241 more virulent than others. When virulence is too high, the host is likely to die before it has a 242 chance to emerge and transmit the virus to other bees via feeding or faeces. Thus, viruses that 243 are too virulent will be selected against. The arrival of a vector changes the dynamics, as now 244 even highly virulent strains can be transmitted if they manage to get into the vector. But such 245 an increase in the prevalence of highly virulent viruses is bound to be temporary if the vector 246 is killed in the process. Because a vector such as Varroa depends on the bee to complete its 247 development (the female mites emerge from the brood cell together with the emerging bee), its 248 arrival will not improve long-term transmissibility of virulent variants, thus leading to the 249 succession from highly virulent viral species to less virulent species as documented in New 250 Zealand 10 . 251
The last few years have seen a surge in publications that link the arrival of Varroa to the 252 emergence of specific strains of DWV 9,10,22-24 . Initially it was thought that DWV strain A was 253 the most virulent strain while strain B was considered to be more benign 22,32 . However, this 254 simple interpretation now seems questionable, as recently strain B has been associated with 255 colony losses 17 and appears to be more virulent in an experimental setting 20 . Regardless, the 256 prevailing wisdom is that Varroa has led to a change in virulence of an otherwise relatively 257 benign virus by changing the virus' mode of transmission, thus modifying the virulence-258 transmission tradeoff 9 . The association between DWV and Varroa is so strong, that many now 259 claim that it is the virus that needs to be controlled, not the mite, if we want to protect the bees. 260
We offer experimental evidence for an alternative explanation for the association between trace of DWV has been identified in previous surveys, including our own. In addition, we did 280 not detect DWV in our serial transmission experiment or in subsequent next generation 281 sequencing of controls (see further). We thus conclude that our bees were naïve to DWV. 282 283 1. Serial transmission experiment 284
Inoculum preparation 285
We modified the extraction protocol from Roberts and Anderson 34 . For our first serial 286 transmission experiment, we sampled healthy, DWV-naïve adult bees collected from hive 287 entrances of three separate colonies (colonies 1, 2 and 3, Figure 1A ). For each colony, we 288 crushed the thorax and abdomen of five bees in 2ml 0.5 M potassium phosphate buffer (pH 8), 289 removed the lysate by pipetting, then added 5% v/v diethyl ether and 10% v/v chloroform and 290 centrifuged the tubes at 12,000 rpm for 2 minutes. We removed the supernatant and filtered it 291 through a 0.22 µm bacterial filter to remove non-viral pathogens. We then diluted the extracts 292 with potassium phosphate buffer by a factor of 10 -3 . Dilution was necessary because injection 293 of undiluted honeybee extract rapidly kills pupae, potentially due to carryover of toxic 294 metabolites (J. Roberts; personal communication). This dilution factor was chosen based on 295 pilot experiments, where we injected 10-fold serial dilutions of adult and pupal bee extracts into concentration that showed no signs of lethality 1 day post-injection. We added 10% v/v green 298 food dye to the bee extract prior to injection to check if injections had been successful. We 299 injected the DWV-free inoculum obtained from each colony into pupae obtained from the same 300 three colonies (1, 2 and 3) as described below. 301
To obtain DWV for our second serial transmission experiment, we sourced bees visibly 302
showing symptoms of DWV from the top bars of frames from Varroa infected colonies in New 303
Zealand (see below for Quarantine details). We cut the thorax and abdomen of five adult bees 304 sagitally in halves and used one half of each bee for inoculum preparation as described above. 305
We kept the other half at -70°C under quarantine conditions for later whole-transcriptome 306 sequencing. We used DWV-containing inoculum as the starting material for injecting into three 307 independent colonies (colonies 4, 5 and 6) as described below. 308 309
Injection Procedure 310
We took 75 white-eyed pupae from their brood comb from each of the six experimental 311 colonies, and distributed pupae into three treatment groups of 25: experimental, buffer and 312 control. We injected the experimental group with 2 µL of initial honeybee inoculum using a 313
Hamilton 10 µl syringe and a 0.3mm needle. As described above, pupae from colonies 1, 2 and 314 3 were injected with 2µl inoculum taken from DWV-free, asymptomatic nestmate bees, and 315 pupae from colonies 4, 5 and 6 were injected with inoculum obtained from DWV-symptomatic 316 bees from New Zealand (Figure 1 A) . We injected the buffer group (procedural control) with 2 317 µL of potassium phosphate buffer to control for the effect of injection. Experimental and buffer 318 group pupae were injected between the fourth and fifth abdominal tergites. We did not perform 319 any further manipulations on the control group. After injections we placed pupae in petri dishes 320 lined with filter paper soaked in 12% glycerol and incubated them at 34.5°C. All pupae were 321 stored in the lab in our approved quarantine facility under quarantine conditions. After 4 days, 322
we froze the pupae at -70°C until required. To prepare for the next round of injections we 323 selected five pupae for extraction using a random number generator. We randomly selected 324 another five to determine viral levels using real-time quantitative PCR, and kept the remaining 325 fifteen in reserve. Extracts from previous transmission cycles were then injected into the next 326 round of white-eyed pupae collected from brood combs originating from the same six 327 experimental colonies. For the DWV-naïve transmission experiment, we concluded a total of 328 20 transmission cycles for colonies 1 and 2 whereas the third colony replaced its queen so that 329 we were unable to collect pupae beyond 18 transmission cycles. For our DWV-positive the queen from colony 6 was replaced during the 4 th transmission cycle and thus this colony 332 was excluded from any further analysis. 333 334
Detection of viruses 335
We used end-point PCR to screen for the presence of viruses in our starting colonies. We used 336
Trizol (Life Technologies) to extract RNA from 12 uninjected bees collected from colonies 1-337 3 at the beginning of the first serial transmission experiment. For our second serial transmission 338 experiment we extracted RNA from 6 pupae from colonies 4-6, sampled at the time of 339 transmission cycle 1. We quantified RNA using a Qubit Broad Range Assay (Life 340 Technologies), and normalised to 200 ng/µl before treatment with DNAse. We synthesised first 341 strand cDNA from 0.5µg total RNA using SuperScript III Reverse Transcriptase (Invitrogen) 342 and random hexamer primers. We performed PCRs to screen for presence of BQCV, SBV, 343 IAPV and Lake Sinai Virus (LSV), as these viruses are most commonly found in Australian 344 bees 21 , using the primers described in Table S1 with an initial 5 min denaturing step at 94 °C, 345 followed by 38 cycles of 94 °C for 1 min, annealing temperature for 1 min and 72 °C for 1 min 346 per kb of product, with a final extension step for 10 min at 72 °C. We visualised PCR products 347 on a 1.5% agarose gel using SYBR Safe DNA stain (Life Technologies). Positive PCR products 348 were sequenced by Macrogen and identity confirmed by BLAST to NCBI GenBank online 349
database. 350
We screened for viruses throughout the experiment using endpoint PCR at various timepoints. 351
For serial transmission experiment 1, we examined 5 pupae from all three treatment groups at 352 transmission cycles 1, 5, 7, 10, 13 and 15. For serial transmission experiment 2 we examined 3 353 pupae from all treatment groups at transmission cycles 1, 10, and 20 to validate the presence of 354 DWV in our experimental group, and the absence of DWV from our buffer and control groups. 355 356
Assessment of virus levels 357
Serial transmission experiment 1-Quantitative Real-time PCR 358
To compare the viral titres between colonies 1-3 after serial transmission with extracts sourced 359 from DWV-naïve bees, we collected white-eyed pupae from an independent colony to 360 standardise for colony background. We injected bee extracts from experimental groups of 361 colonies 1-3, from transmission cycles 1, 5, 7, 10, 15 and 20 (cycle 18 for colony 3), into 10 362 white-eyed pupae, along with 10 buffer-injected procedural controls and 10 uninjected 363 (unmanipulated) controls (see Figure 1 B for a schematic representation of the experiment). We 364 randomly selected five pupae from each group and extracted RNA from each pupa separately 365 in 1 mL of Trizol. We treated the RNA with DNAse and performed cDNA synthesis using the same method described above. We then diluted cDNA to a final concentration of 27 ng/µl. We 367 created negative controls for the qPCR assay by pooling extracted RNA from samples drawn 368 from the same treatment group and transmission cycle, treating them with DNAse and mixing 369 them with all the reagents for cDNA synthesis except the reverse transcriptase enzyme. We 370 created the standards for our qPCR assay by taking previous cDNA samples with high levels 371 of SBV and BQCV, then performing a serial dilution over 3 orders of magnitude. 372
We designed qPCR primers to amplify SBV and BQCV and used previously published 373 primers for β-Actin, Ef1-α, and Rps5, which served as endogenous controls (Table S1 ). We 374 confirmed the specificity of each primer pair via melt-curve analysis and gel electrophoresis. 375
We performed the assay using a Roche LightCycler 480 using 2x SYBR Master Mix (Roche 376 Technologies). We pre-incubated the reactions (95°C, 10 minutes) prior to 45 amplification 377 cycles (95°C, 10 seconds; 58°C 10 seconds; 72°C, 10 seconds), and measured fluorescence at 378 each extension step. We obtained Cq values using the second derivative maximum method 379 using the Roche LightCycler 480 software. The same software was used to calculate the 380 efficiencies of each set of primers from the standard curves on each plate. 381
382
Statistical analysis -quantitative real-time PCR 383
We compared the stability of each reference gene in Bestkeeper 35 and used the two most stable 384 reference genes, Actin and Rps5, to normalise the expression of BQCV and SBV in all samples. 385
The expression level of each gene was calculated as E Cq min -Cq i, where E is the efficiency of the 386 primers calculated, Cqmin is the lowest Cq value for a given gene and Cqi is the Cq of sample i. 387
The expression of each of SBV and BQCV in each sample was then normalised against the 388 geometric mean of the expression levels for both reference genes to obtain the final relative 389 expression score 36 . To compare the viral titres between each transmission cycle and between 390 colonies 1-3 in our pupal quantitative PCR, we performed a one-way ANOVA (Table S2) . 391 392
Serial transmission experiment 2-Whole transcriptome RNA sequencing 393
To compare virus levels between colonies 4 and 5 after serial transmission with DWV-394 inoculum, we extracted RNA from five randomly selected pupae 4 days post-injection for each 395 of transmission cycles 1, 10, 20 and 30, as well as buffer injected and unmanipulated control 396 pupae from transmission cycle 20. We also extracted RNA from five pupae from transmission 397 cycle 20 from colonies 1 and 2 from serial transmission experiment 1 (DWV-naïve 398 transmission). Finally, we extracted RNA from our DWV source population, using the stored 399 half of adult bees from which the haemolymph containing DWV was initially extracted (see 400 Figure 1 B for schematic). We extracted RNA using 1mL Trizol as outlined above. After DNase treatment, we used an RNeasy Mini Kit (Qiagen) to clean RNA to a total of ≥5µg. Cleaned 402 RNA was diluted to a minimum of 100ng/µL into a 50µL aliquot and stored at -70°C until it 403 was shipped on dry ice to the Australian Genome Research Facility (AGRF) laboratory 404 (Melbourne, Australia) for preparation of whole transcriptome, 100bp paired-end library with 405 ribosome depletion (Ribo-zero Gold (human/mouse/rat)), and HiSeq (Illumina) sequencing. 406
We multiplexed fifteen libraries across two lanes, providing between 3.13-4.2 Gb data per 407 library, for a total data yield of 56.74 Gb. The raw sequencing reads from this project have been 408 deposited to Genbank under the Bioproject ID PRJNA397460 at the Sequence Read Archive 409 (SRA Study ID: SRP114989). 410 411
Sequencing -data analysis 412
We performed an intial de novo assembly of sequencing reads for each sample using Trinity 37 . 413
To determine which honey bee viruses were present, we used BLAST searches to compare 414 Trinity-assembled contigs to a custom honey bee virus database containing all currently known 415 honey bee virus genome sequences. We found contigs matching to BQCV and SBV in all 416 samples. DWV contigs were present in assemblies from the DWV source population and cycles 417 1-30 of the DWV serial transmission experiment. In addition, the DWV source population also 418 contained contigs matching to the recently described Apis Rhabdovirus 1 and 2 (ARV-1 and 419 ARV-2) 38 . However the levels of these viruses were below 0.05% of the total RNA reads ( Table  420 S3), and were subsequently not detected in any further transmission cycles. We found no other 421 viruses in our samples. Interestingly, short contigs for DWV were also assembled from our 422 buffer injected and unmanipulated controls. Previous studies using Illumina HiSeq and MiSeq 423 technology have reported 'sample bleeding' due to reads being incorrectly assigned to the wrong 424 sample source when multiplexed in the same sequencing lane 20,39 . To assess the level of DWV 425 read misassignment in our buffer and control samples, we aligned sequencing reads of each 426 sample to DWV-A and DWV-B genomes using Bowtie2 40 . All control samples showed less 427 than 0.02% of total reads aligning to DWV. This level was similar to the level of multiplex 428 sample bleeding that we observed in a negative control sample. In addition, we were unable to 429 amplify DWV using PCR from cDNA synthesised from our buffer and control samples, 430 therefore we concluded that the DWV contigs present in our controls are a result of inaccurate 431 sample assignment of reads during the multiplexed HiSeq sequencing run. 432
Prior to analysing the viral content of our transcriptomes, we assessed the proportion of 433 residual ribosomal RNA (rRNA) reads, as complete ribosome depletion may not be obtained 434 when using Ribo Zero Gold (human/mouse/rat) for invertebrate samples. We identified Apis using Bowtie2. The percentage of residual rRNA reads ranged from 2.5 -46% of total RNA 437 reads per library (Table S3) . These values were factored into any subsequent viral percentage 438
calculations. 439
To determine the viral content in each treatment condition, we aligned sequencing reads of 440 each sample to BQCV, SBV, DWV-A and DWV-B genomes using Bowtie2. We used 441 representative SBV and BQCV contigs assembled de novo from our samples as the template 442 for Bowtie2 alignments, as our SBV and BQCV strains differed significantly to the reference 443 SBV 
Pupal survival screen 456
To assess the virulence of the viruses contained in the inoculum generated after serial 457 transmission cycles in experiment 1 (containing SBV/BQCV) and experiment 2 (containing 458 DWV/SBV/BQCV), we developed a mortality assay using change in pupal eye colour to 459 determine pupal mortality. As pupae develop, pigments such as ommochromin are deposited in 460 the compound eyes and ocelli, causing a change in colour from white, through pink and red, to 461 the endpoint black 44 (see Figure S2 ). By comparing the colour of a pupa's eyes over consecutive 462 days, we developed an assay that allowed us to determine the point in time a pupa died. A pupa 463 was determined to have died when its eyes had ceased changing colour over two consecutive 464 photographs, and/or when the compound eye had retracted from the cuticle ( Figure S2 ). 465
We sourced pupae from 2 independent honeybee colonies and injected them with inoculum 466 as per our serial transmission protocol. We injected inoculum from transmission cycle 20 from 467
Colony 1 (BQCV/SBV) and Colony 4 (DWV/BQCV/SBV) for the first trial, and Colony 2 and 468
Colony 5 for the second trial, along with the DWV source inoculum, buffer and unmanipulated 469 controls (12 pupae per replicate, 5 replicates per colony, see Figure 1 B for schematic). We 470 placed pupae into 0.6mL 96 well PCR plates so that we could monitor their development by taking photographs of their eyes two times per day. We used a 1.5% w/v agar gel as a substrate 472 to maintain moisture and standardise the height of pupae, and added 0.01g 100mL -1 copper 473 sulphate to the hot agar prior to pouring in order to inhibit fungal growth. We photographed 474 pupae using a Nikon D5100 camera with a Tamron 60mm F/2 macro lens and terminated the 475 experiment at day 6 prior to eclosion. 476 477
Statistical analysis -survival screen 478
We compared the pupae's survival with Cox's proportional hazards survival analyses using R-479 3.3.3 45 with the package survival 46 . We checked the log-linearity of covariates by plotting the 480 Cox models' martingale residuals against fitted values 47 . We checked the proportional hazards 481 assumption of the Cox regression models following Grambsh & Therneau 48 (all p > 0.05). In 482 each Cox model we investigated for each colony the effect of 'treatment' (i.e. control, buffer, 483 pure DWV, serially transmitted BQCV and SBV, serially transmitted BQCV, SBV and DWV) 484 on pupae survival. We also included 'replicate' as a covariate, as well as the interaction between 485 treatment and replicate in all models. Since this interaction proved to be non significant in both 486 models (respectively colony 1: p = 0.214 and colony 2: p = 0.244), we removed the interaction 487 and recalculated the model. Post-hoc p-values were corrected for multiple comparisons 488 following the Benjamini we require a quarantine permit that restricts us from injecting imported viruses into adult bees. 495
However, we are permitted to inject into pupae provided we terminate experiments prior to 496 eclosion. Therefore, we injected inoculate into white-eyed pupae, and we terminated each cycle 497 after 4 days to enable sufficient time for viral replication, while avoiding eclosion (Figure 1 A) . Table S2 for 664 details of the statistical analyses. 
